This cased-based panel focuses on the guideline recommendations and evidentiary basis for EBRT for HCC and IHC.

This panel of speakers examine four different aspects of patient-oriented factors that will allow the practicing radiation oncologist to better recommend, direct, and evaluate the results of therapy for women with gynecologic cancers.

Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca).

This course guides the audience through a very practical approach to work up and management of an HPV+ tonsil cancer patient (T1N1), from initial examination and work-up through late complications.

The course consists of two debates. The first debate consists of two thoracic oncologists with one arguing for the use of surgery and one against the use of surgery for patients with stage III NSCLC.

The course presents a review of recent changes in the management of resected NSCLC as well as the management of patients with early stage NSCLC treated with SBRT. The four main topics are:

Radiation is an integral component of the treatment of small cell lung cancer, as a definitive treatment for limited stage disease, as prophylactic cranial irradiation for prevention of brain metastases, as consolidation to the chest in extensive stage disease, and for palliation.

The prediction of treatment outcomes for individual patients or patient populations, including tumor control and normal tissue toxicity, has always been of tremendous importance for driving clinical practice in Radiation Oncology and at the same time has been an active area within the research co

The course has two components. First, the moderator leads a discussion among the panelists of pre-selected difficult cases.

This course presents challenging cases of women with cervix cancer, either due to poorly studied disease subsets (e.g.